Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
06/2010
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010US20100152045 Phenylalkyl Substituted Heteroaryl Derivatives
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/16/2010EP1981858B1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
06/15/2010US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients
06/15/2010US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
06/10/2010US20100144733 Compounds, compositions and methods comprising heteroaromatic derivatives
06/09/2010EP2193126A1 Oxadiazole diaryl compounds
06/09/2010CN101723941A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5
06/09/2010CN101723912A 2-[5-(2-hydroxyphenyl)-1,3,4-oxadiazole-2-thioether]-1-acetophenone compounds
06/03/2010WO2009034396A3 Method and means relating to multiple herbicide resistance in plants
06/03/2010US20100137381 Acetamide derivatives as potassium channel modulators
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/02/2010EP2190852A1 Bicyclic sphingosine 1-phosphate analogs
06/02/2010EP2190290A2 Method and means relating to multiple herbicide resistance in plants
06/02/2010CN101274916B Multifunctional bipolar carrier transmission material and application thereof
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
05/2010
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/25/2010US7723553 organic electroluminescent device; flat-panel displays
05/25/2010US7723365 Mitotic kinesin inhibitors
05/25/2010US7723362 for controlling acarina
05/19/2010EP1706372B1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
05/18/2010US7718679 Heteroaryl carboxamides
05/18/2010US7718678 diamino-substituted 1,2,5-oxadiazoles for treatment of cancer, gingivitis, antiatherosclerosis, as viricide, aniinflammatory agent, antiogenesis inhibitor and analgesic
05/13/2010US20100121071 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
05/13/2010US20100121070 Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds
05/13/2010US20100120876 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mc4) agonist peptide
05/13/2010US20100120874 Heterocyclic gamma secretase modulators
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120764 Di-substituted amides for enhancing glutamatergic synaptic responses
05/13/2010US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
05/12/2010EP2183230A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours
05/12/2010CN1736371B Selective androgen receptor modulators and methods of use thereof
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010US20100113528 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/04/2010US7709509 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
04/2010
04/29/2010WO2010047400A1 Method for producing oxadiazolinone compound and intermediate thereof
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators
04/27/2010US7705024 cannabinoid receptors modulators; metabolic syndrome, obesity, hyperlipidemia, type II diabetes, atherosclerosis, substance addiction, liver cirrhosis, schizophrenia, sexual dysfunction, anxiety; 5-(5-(5-bromoselenophen-2-yl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-3-tert-butyl-1,2,4-oxadiazole
04/27/2010US7704543 Obtaining a high density, reproducible and uniform coverage of a solid surface suitable for solid state synthesis and biosynthesis; aminosilanation of activated glass reacted with a diester of trimesic acid and N-hydroxysuccinimide followed by hydrolysis; attaching of DNA, proteins, biopolymers
04/22/2010WO2010045258A2 Spirocyclic gpr40 modulators
04/22/2010WO2010012442A3 Insecticidal benzenedicarboxamide derivative
04/22/2010CA2739888A1 Spirocyclic gpr40 modulators
04/22/2010CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
04/21/2010EP2176260A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents
04/20/2010CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010CN101693699A Synthesis method of 3,4-bi(4'-nitrophenyl) oxidized furoxan
04/13/2010US7696353 Liquid crystalline free radical polymerizable monomer; low wavelength dispersiveness, high Delta n; uniform, fixed alignment; retarders
04/08/2010US20100087495 Phenyl derivatives and their use as immunomodulators
04/08/2010US20100087491 Polycyclic compounds
04/08/2010US20100087464 Protein kinase inhibitors and methods for using thereof
04/07/2010EP2170850A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
03/2010
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/30/2010US7687492 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/30/2010US7687491 Immunosuppressants with low toxicity; 1-({4-Methyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl}methyl)azetidine-3-carboxylic acid for example; autoimmune diseases and transplant rejection; N-substituted azetidine, pyrrolidine or piperidine compounds
03/30/2010CA2423631C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
03/25/2010US20100075974 Heterocyclic gpr40 modulators
03/24/2010CN101679267A Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
03/23/2010US7683082 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069367 LXR and FXR Modulators
03/17/2010EP1554361B1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/16/2010US7678922 Processes for the preparation of 1,2,4-oxadiazole benzoic acids
03/16/2010US7678820 Hetero compound
03/11/2010US20100063297 Processes for the preparation of 1,2,4-oxadiazole benzoic acids
03/11/2010US20100063296 Composition for treating infectious diseases caused by helicobacter
03/11/2010US20100060155 Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same
03/10/2010CN101665469A Heterocyclic compounds useful as Nurrl activators
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/04/2010WO2010023448A1 Novel potassium channel blockers
03/04/2010US20100056777 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/02/2010US7671075 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide
03/02/2010US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors
03/02/2010US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents
02/2010
02/25/2010WO2010020305A1 Oxadiazole derivatives for treating diabetes
02/25/2010US20100048648 Thiophene derivatives as S1P1/EDGE1 receptor agonists
02/25/2010US20100048639 Oxadiazole derivates as s1p1 receptor agonists
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048587 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
02/25/2010DE102008038220A1 Oxadiazolderivate Oxadiazole
02/25/2010CA2734397A1 Oxadiazole derivatives for the treatment of diabetes
02/18/2010WO2010019772A2 Oxadiazole-2-oxides as antischistosomal agents
02/18/2010WO2010019098A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
02/18/2010WO2010019097A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 72